← Latest Filings
C
Chimovits Erez
Open-market buys
3
$36.0M total
Open-market sells
0
$0 total
Tracking since
Aug 2026
Activity timeline
Open-market buy — $1.0M
ADARx Pharmaceuticals, Inc. · Sep 28, 2026
Open-market buy — $4.9M
Braveheart Bio, Inc. · Aug 7, 2026
Open-market trades from the last two years.
Holdings as last reported
9,292,025 Common Stock in ADRX
Held indirectly (See footnotes) · as of 2026-09-28
1,102,739 Common Stock in BRVE
Held indirectly (By OrbiMed Private Investments IX, LP) · as of 2026-08-05
Companies touched
ADARx Pharmaceuticals, Inc.
CIK 0001802369
Upstream Bio, Inc.
CIK 0002022626
